Literature DB >> 10639253

Lethal Reperfusion Injury: Does Anyone Still Care?

.   

Abstract

Year:  1997        PMID： 10639253     DOI： 10.1023/a:1017564331972

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  13 in total

1.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

Review 2.  Reperfusion in acute myocardial infarction. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion.

Authors: 
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

3.  Ischaemic preconditioning: can the protection be bottled?

Authors:  M V Cohen; J M Downey
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

4.  Myocardial reperfusion: a double-edged sword?

Authors:  E Braunwald; R A Kloner
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

5.  Modification of myocardial infarction size after coronary occlusion.

Authors:  P R Maroko; E Braunwald
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

6.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

7.  The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.

Authors:  K A Reimer; R B Jennings
Journal:  Lab Invest       Date:  1979-06       Impact factor: 5.662

8.  Reperfusion injury induces apoptosis in rabbit cardiomyocytes.

Authors:  R A Gottlieb; K O Burleson; R A Kloner; B M Babior; R L Engler
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

Review 10.  Myocardial protection during surgical coronary reperfusion.

Authors:  E R Rosenkranz; G D Buckberg
Journal:  J Am Coll Cardiol       Date:  1983-05       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.